REFERENCES
1. Seta V, Gaouar H, Badaoui A, Francès C, Barbaud A, Soria A. Low-dose
provocation and skin tests in patients with hypersensitivity to
gadolinium-based contrast agents. Clin Exp Allergy 2019;49:724-728.
2. Mankouri F, Gauthier A, Srisuwatchari W, et al. Hypersensitivity to
gadolinium-based contrast agents: A single-center retrospective analysis
over 7 years. J Allergy Clin Immunol Pract 2021;9:1746-9.e2
3. Walker DT, Davenport MS, McGrath TA, et al. Breakthrough
hypersensitivity reactions to gadolinium-based contrast agents and
strategies to decrease subsequent reaction rates: A systematic review
and meta-analysis. Radiology 2020;296(2):312-321.
4. Gallardo-Higueras A, Moreno EM, Muñoz-Bellido FJ, et al. Patterns of
cross-reactivity in patients with immediate hypersensitivity reactions
to gadobutrol. J Investig Allergol Clin Immunol 2021;31:504-506
5. Rodriguez-Nava G, Kesler AM, Carrillo-Martin I, Gonzalez-Estrada A.
Gadolinium-induced anaphylaxis with positive skin test results. Ann
Allergy Asthma Immunol. 2019;122:654-655
6. Vega F, Múgica MV, Bazire R, et al. Adverse reactions to iodinated
contrast media: Safety of a study protocol that includes fast full-dose
parenteral challenge tests searching for an alternative contrast media.
Clin Exp Allergy 2020;50:271-274.